Press Releases
Companion Diagnostics Market: Easing of Regulatory Policies to Drive the Demand

Companion Diagnostics Market

, 22 February 2018 -- The global companion diagnostics market is estimated to reach US$5.6 billion by 2019, increasing from US$1.8 billion in 2013.

Due to the dominance of the top three players in the global companion diagnostics market, the nature of the market is highly oligopolistic, says Transparency Market Research in a new study. The leading companies operating in the market are focusing on protecting their patent rights to retain exclusivity. The top three companies in the companion diagnostics market are Roche Holdings followed by Qiagen N.V., and Agilent Technologies. Together they comprise approximately 80.4% of the overall global market in 2012.

Report Overview @

In order to rake in a greater share of revenues, many small and large players are competing to co-develop companion diagnostics by collaborating with pharmaceutical manufacturers. In this regard, companies are also seeking defensive patents for their technology, products, and tests to restrain other companies from the usage of their exclusive tests.

Companion diagnostics include two types of tests namely tests which are developed along with target drugs and the other developed after the commercialization of drugs. Companion diagnostics combined with targeted therapeutics are being seen as a major breakthrough in the personalized medicine field. Companies operating in the companion diagnostics market are seeking an effective growth strategy in the development of this concept drug-diagnostic interaction as the healthcare sector is shifting its focus towards personalized medicine.

Request for Sample Copy of Report @

According to TMR analyst, the implementation of well-structured regulatory policies will help in the development of effective companion diagnostics leading to a growth in the market. As a result of the FDA guideline in the U.S. regarding the approval of targeted therapeutic along with its companion drug, two targeted therapeutics, one of Abbott Laboratories and the other of Roche Holdings, were approve along the line. Currently, various regulatory agencies around the world are in support for the use of companion diagnostics for the development and commercialization of prescription drugs used in targeted therapeutics. Thus, the change in regulatory policies is expected to boost the adoption of companion diagnostics globally.

As the companion diagnostics field is still in its infancy, the opinions of various institutions, organizations, societies, and groups have a deep impact on the acceptance of these diagnostics.

Request a Brochure of the Report @

The opinions and reviews of clinical societies and advocacy groups are likely to influence the end users leading to hampering the sales and acceptance of companion diagnostics. However, many clinical societies and advocacy groups also promote the use and acceptance of these tests.

The expansion of companion diagnostics into new areas such as oncology, CNS disorders, infectious diseases, and metabolism disorders has provided the companies of companion diagnostics with new growth opportunities. Different pharmaceutical and diagnostics companies are investing in the development of companion drugs and due to the expansion in the application scope, these companies are expected to gain substantial growth opportunities.

Enquiry for discount on this report @

The global companion drugs market is expected to grow at 18.1% CAGR from 2013 to 2019 to reach US$5.58 bn by 2019. The market was worth US$2.80 bn in 2015. North America is projected to dominate the market until 2019 with a market worth US$2.18 bn, followed by Europe. The breast cancer companion diagnostic segment is estimated to lead the global market in terms of indication by 2019 with a market worth US$2,531.4 mn.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

# # #

Submitted by hawer on Thursday, 22 February 2018 at 3:52 PM
Category: Health Care & Medical
Related News

PromarkerD Diagnostic Test Leader Officially Launched
Tuesday, 20 Mar 2018

PromarkerD Diagnostic Test Leader Officially Launched
Tuesday, 20 Mar 2018

Thrombin Market to Reach US$ 690.1 Million by the End of 2025
Monday, 19 Mar 2018

Extracorporeal Membrane Oxygenation Machine Market: Adoption of ECMOs in ICU to Spike Demand
Monday, 19 Mar 2018

Insights of Corporate Wellness Services Market in US Industry : Development and Forecast 2018-2021
Monday, 19 Mar 2018

Related Events

Imaging in Hawaii
Monday, 19 Mar 2018

12th annual Paediatric Clinical Trials
Monday, 19 Mar 2018

9th Proactive GCP Compliance
Monday, 19 Mar 2018

20th Annual Superbugs and Superdrugs
Monday, 19 Mar 2018

ICI Boston Summit
Monday, 19 Mar 2018

Latest News

Prestressed Concrete Market to Expand with Significant CAGR During 2025
Tuesday, 20 Mar 2018

Ballast Water Management Market to Observe Strong Development by 2025
Tuesday, 20 Mar 2018

Boiler, Turbine, and Generator (BTG) Market to Witness Exponential Growth by 2025
Tuesday, 20 Mar 2018

Calcium Channel Blocker Market Progresses for Huge Profits During 2025
Tuesday, 20 Mar 2018

Terephthaloyl Chloride Market to Record Sturdy Growth by 2025
Tuesday, 20 Mar 2018

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 20 March 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Topological States in Strongly Interacting Light-Matter Systems
  • Argus California Carbon and LCFS Summit
  • Imaging in Hawaii
  • 9th Proactive GCP Compliance
  • 12th annual Paediatric Clinical Trials

  • Latest Jobs
    Sorry, there are currently no entries posted here.